Sbc Medical Group Holdings Incorporated · NASDAQ:SBC
Sbc Medical — Q1 2026 Earnings Presentation
17 slides from Sbc Medical's earnings presentation, May 14, 2026
Slide 1: 1Q 2026 Investor Presentation
1Q 2026 Investor Presentation May 2026
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain
Slide 3: Table of Contents
Table of Contents Ⅰ. 1Q 2026 Clinic Highlights P4 Ⅱ. 1Q 2026 Performance Highlights P6 Appendix. P10 3
Slide 4: 1Q 2026 Clinic Highlights
Ⅰ. 1Q 2026 Clinic Highlights 4
Slide 5: 1Q 2026 Clinic Highlights
1Q 2026 Clinic Highlights • Both total and same-clinic revenues increased, due to growth in the number of customers and average revenue per visit Clinics Key Figures Number of Locations 1 Total Revenue 1 2 3 4 Average Revenue per Visit 1 2 3 5 6 7 (as of Mar 31, 2026, YoY) (1Q - YoY) (1Q - YoY) 284
Slide 6: 1Q 2026 Performance Highlights
Ⅱ. 1Q 2026 Performance Highlights 6
Slide 7: Consolidated Income Statement
Consolidated Income Statement • YoY: Point revenue increase offset by fee revision impact; revenue declined overall • QoQ: Revenue increased primarily from higher point-related fee income Total Revenues (MM US$) 1Q26 4Q25 1Q25 % QoQ % YoY YoY Total revenues 43 +9% (9)% 40 47 • Fee revision impact: U
Slide 8: Revenue Bridge Analysis (vs. 1Q 2025)
Revenue Bridge Analysis (vs. 1Q 2025) • Excluding fee structure revisions USD (8.7) MM, underlying revenue grew +11% YoY (MM US$) +4.4 +1.3 +5.6 +2.1 +1.2 (8.7) (0.4) (2.2) (2.0) 47.3 43.1 44.3 39.9 c0 c2 c3 c4 c5 c6 c7 c8 c9 c10 c11 c12 1Q25 Difference in Fee 1Q25 Franchising Procurement Mgmt. Rent
Slide 9: EBITDA Bridge Analysis (vs. 1Q 2025)
EBITDA Bridge Analysis (vs. 1Q 2025) • Underlying EBITDA ¹ grew +17% excluding fee structure revision USD (8.7) MM (MM US$) +2.8 +4.4 +0.7 +0.5 +0.2 (2.9) (0.2) (8.7) 24.8 18.4 18.9 16.1 25年Q1 フィー改 定 調整後 売上高 調整後売 上原価 給与・手 当 コンサル その他 26年Q1 FX 26年Q1 25年Q1 FX調整後 1Q25 Fee Structure 1Q25 Revenue Adjusted
Slide 10: Appendix
Appendix. SBC Medical Group eer 10
Slide 11: 1Q 2026 Financial Highlights
1Q 2026 Financial Highlights Total EBITDA 2 EBITDA 3 Net Income ROE 4 Basic EPS 5 Attributable to Revenues Margin SBC Medical Group (Annualized) Holdings Incorporated 1Q 2026 $43MM $19MM 43% $11MM 18% $0.11 (YoY) (9)% (26)% (10)pt (47)% (23)pt (48)% 1 Converted at JPY 156.9 / USD 2 EBITDA = Income f
Slide 12: Consolidated Income Statement
Consolidated Income Statement (MM US$) 1Q26 1Q25 % YoY Total Revenues 43 (9)% 47 • Franchising revenue 9 (42)% 16 • Procurement revenue 12 (14)% 14 • Management services revenue 12 +37% 9 • Rental services revenue 3 (39)% 6 • Other revenues 6 +115% 3 Cost of Revenues 13 +32% 10 Gross Profit 30 (20)%
Slide 13: Consolidated Balance Sheet
Consolidated Balance Sheet Mar. Dec. Mar. Dec. (MM US$) (MM US$) 2026 Change 2025 2026 Change 2025 TOTAL ASSETS 388 +8 380 TOTAL LIABILITIES 118 +1 117 Total Current Assets 239 +8 231 Total Current Liabilities 63 +2 61 • Cash and cash equivalents 167 +3 164 • Accounts payable 19 +2 17 • Accounts rec
Slide 14: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (MM US$) 1Q26 1Q25 Change Net cash provided by operating activities 9 +7 2 Net cash used in investing activities (1) 0 (1) Net cash used in financing activities (2) (2) (0) Effect of exchange rate changes (3) (9) 6 Net change in cash and cash equivalents 4 (3) 7 Cash
Slide 15: Strong Financial Foundation for Growth
Strong Financial Foundation for Growth • A sound financial foundation with ample cash reserves and borrowing capacity to support future growth investments Balance Sheet Key Figures (as of March 31, 2026) Cash and Cash Equivalents Interest-bearing Liabilities ² Net Interest-bearing Liabilities ⁴ $167
Slide 16: Non-GAAP Financial Measures
Non-GAAP Financial Measures This presentation references certain non-GAAP financial measures. Reconciliations of such measures to the most directly comparable GAAP measures are shown below. Reconciliation Table on Non-GAAP Financials (MM US$) 1Q26 4Q25 1Q25 (A) Total Revenues 43 40 47 (B) Income fro
Slide 17: Thank you
Thank you IR Contact / ir@sbc-holdings.com
SBC Medical Group Holdings — Q1 2026 Earnings Presentation on 6ix